Your browser doesn't support javascript.
loading
A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202).
Voorhees, Peter M; Suman, Vera J; Tuchman, Sascha A; Laubach, Jacob P; Hassoun, Hani; Efebera, Yvonne A; Mulkey, Flora; Bova-Solem, Misty; Santo, Katelyn; Carlisle, Destin; McCarthy, Philip L; Richardson, Paul G.
  • Voorhees PM; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
  • Suman VJ; Alliance Statistics and Data Center, Rochester, Minnesota, USA.
  • Tuchman SA; Division of Hematology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Laubach JP; Department of Hematology and Oncology, Dana-Farber/Partners Cancer Care, Harvard Medical School, Boston, Massachusetts, USA.
  • Hassoun H; Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Cancer Center, New York, New York, USA.
  • Efebera YA; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Mulkey F; Alliance Statistics and Data Center, Duke University, Durham, North Carolina, USA.
  • Bova-Solem M; Alliance for Clinical Trials in Oncology, Protocol Operations Program, Chicago, Illinois, USA.
  • Santo K; Alliance Statistics and Data Center, Rochester, Minnesota, USA.
  • Carlisle D; Alliance for Clinical Trials in Oncology, Protocol Operations Program, Chicago, Illinois, USA.
  • McCarthy PL; Transplant and Cellular Therapy Program, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  • Richardson PG; Division of Hematology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
Am J Hematol ; 96(12): 1595-1603, 2021 12 01.
Article en En | MEDLINE | ID: mdl-34559902
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Talidomida / Compuestos de Boro / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Inhibidores de Proteasoma / Lenalidomida / Glicina / Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Talidomida / Compuestos de Boro / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Inhibidores de Proteasoma / Lenalidomida / Glicina / Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article